Influence of Baseline Disease Severity Defined by Investigator's Global Assessment on Abrocitinib Efficacy for Up to 96 Weeks in Patients With Moderate-to-Severe Atopic Dermatitis: Interim Analysis of JADE EXTEND, a Long-Term Extension Study

    September 2023 in “ Journal of the American Academy of Dermatology ”
    Melinda Gooderham, Eric L. Simpson, Bob Geng, Linda Stein Gold, Andreas Wollenberg, Saleem A. Farooqui, Fan Zhang, Claire Feeney, Melissa Watkins, Herwig Koppensteiner

    We don't know much about this study yet.

    We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.
    Discuss this study in the Community →